Cardiovascular drugs that increase the risk of new-onset diabetes
- 1 April 2014
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 167 (4) , 421-428
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Trends in C-Reactive Protein Levels in US Adults From 1999 to 2010American Journal of Epidemiology, 2013
- Achievement of Goals in U.S. Diabetes Care, 1999–2010New England Journal of Medicine, 2013
- Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin TherapyJACC, 2013
- Risk scores based on self-reported or available clinical data to detect undiagnosed Type 2 Diabetes: A systematic reviewDiabetes Research and Clinical Practice, 2012
- Pre-Diabetes, Metabolic Syndrome, and Cardiovascular RiskJACC, 2012
- Lifestyle Factors and Risk for New-Onset DiabetesAnnals of Internal Medicine, 2011
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin TherapyJAMA, 2011
- Predictors of New-Onset Diabetes in Patients Treated With AtorvastatinJACC, 2011
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Prediction of Incident Diabetes Mellitus in Middle-aged AdultsArchives of internal medicine (1960), 2007